IMA-Karnataka welcomes doctors to this informative recorded session on "Use of Remdesivir in treating patients with COVID-19 (Experience sharing & Updates from Clinical Trials)"
Introduction of panelist: Dr. Mayuri Keskar, MLH & TC4A and Dr Somnath (Moderator)
What was covered:
Dr. Vishnu Sharma, M.D. Tuberculosis and Respiratory Diseases, shared his experience on "Use of Remdesivir in treating patients with severe COVID-19, case presentations". Dr Sharma started his session with an explanation about Remdesivir. Then he explained the indication dosage of Remdesivir with different case presentations. Dr Sharma shared his experiences in treating COVID patients and what are the indications, observations to start Remdesivir
Dr. Ravindra Mehta, Chief of Critical Care, Consultant pulmonologist/Sleep Medicine Specialties, Apollo Hospitals, Bangalore, shared "Remdesivir in COVID19 - Current status and Practical Issues". Dr Mehta explained about the use of Remdesivir before COVID era. He then explained why the drug is indicated as an antiviral medicine and its use in COVID patients. Dr Mehta explained about the mechanism of action of Remdesivir, and its evidence. He explained compassionate use of Remdesivir with severe COVID-19 patients and is it indicated in renal patients or no. The session was then continued with an explanation about drug interaction.
Panel discussion with Q&A session: After the speaker’s session, panel discussion started followed by Q&A session. The panel shared their experiences answering the questions and answers. Almost all questions were addressed by the speakers
Vote of thanks and Poll: At the end of the webinar Dr Mayuri raised the poll questions for attendees and shared vote of thanks with IMA Karnataka to provide the opportunity to co host the webinar with them. MLH team also thanked respected speakers and moderator for providing their valuable time for sharing their experience in treating COVID-19 and Mylan Pharmaceuticals to make this series of COVID-19 webinars possible
Thank you for showing interest in Use of Remdesivir in treating patients with COVID-19 (Experience sharing & Updates from Clinical Trials). We are sorry that the course is unavailable at the moment. Please leave your contact details and we will notify you of related courses or upcoming dates.